Exciting Discovery Could Lead to New Alzheimer’s Therapies

A researcher in the lab of Rice’s Angel Martí holds a vial of fluorescent dye molecules in solution. Using time-resolved spectroscopy, which tracks the fluorescence lifetime of dye molecules, Martí and collaborators describe a second binding site on amyloid-beta deposits associated with Alzheimer’s disease, opening the door to the development of new therapies. Credit: Gustavo Raskosky/Rice University